We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
London-listed group has signed 50% more clients for its complex cell and gene therapy since end of last year
First example of artificial intelligence helping to accelerate diagnosis of diseases caused by genetic variants
Jonathan Milner says deal materially undervalues Cambridge-based life sciences company
Climate change helps the spread of infectious diseases. Plus: rise in fungal infections highlights risks of antimicrobial resistance; Sydney shows how to almost eliminate HIV transmission; wait goes on for effective Long Covid treatments
Trial finds latest version elicited better immune response than existing jabs
Inceptive’s Jakob Uszkoreit, a pioneer of the technology behind ChatGPT, attracts Nvidia funding to design ‘biological software’
Biotech has been criticised for closing its $8bn acquisition of cancer test company Grail without regulatory approval
Private equity group’s bid for researcher comes as the biomedical market is slowing down post-Covid
Biotech company rejects founder and Republican presidential hopeful’s criticism of US drug regulator
Federal Trade Commission said it secured concessions from pharma company to resolve its competition concerns
Dublin believes that the country’s skill base will attract pharma and medical companies
Suggestion opportunities yielded by lower cost of technology are not adequately recognised by government
Challenges include getting multiple gene edits right, creating artificial wombs and building a herd with sufficient diversity
Drugmaker says it is working on new technologies to develop vaccines for infectious diseases where there is ‘high unmet need’
Illumina-owned cancer testing group allegedly failed to deal with accusations of inappropriate behaviour and racism
US gene sequencing company proceeded with acquisition of cancer test developer even as regulators were probing deal
We have a narrow window during which to harness AI for good, rather than ill
Move by Food and Drug Administration paves way for millions of Americans to access medicine
Medicines produced by pharma group will be for domestic use only
World’s biggest gene sequencing group closed deal with cancer screening start-up despite ongoing investigation
Insilico Medicine says trial of lung disease therapy is milestone for generative AI in drug development
Antitrust challenge may force big pharma groups to rethink ‘pure play’ business models
Drugmakers’ appetite for takeovers surges but FTC action against Amgen raises risks for megadeals
Chief’s resignation follows chair’s departure from gene sequencing group
Pharmaceuticals producer in first court hearing on Monday
International Edition
